Editorial: IBD Management-Novel Targets and Therapeutic Perspectives.
作者信息
Antonioli Luca, Fornai Matteo, Romano Barbara, Pellegrini Carolina, Blandizzi Corrado
机构信息
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Department of Pharmacy, School of Medicine and Surgery, Univeristy of Naples Federico II, Naples, Italy.
出版信息
Front Pharmacol. 2020 Apr 21;11:448. doi: 10.3389/fphar.2020.00448. eCollection 2020.
Abstract
摘要
相似文献
1
Editorial: IBD Management-Novel Targets and Therapeutic Perspectives.社论：炎症性肠病的管理——新靶点与治疗前景
Front Pharmacol. 2020 Apr 21;11:448. doi: 10.3389/fphar.2020.00448. eCollection 2020.
2
Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses.髓源性抑制细胞（MDSCs）在实验性结肠炎和炎症性肠病（IBD）免疫反应中的异常功能。
Autoimmunity. 2017 May;50(3):170-181. doi: 10.1080/08916934.2017.1283405. Epub 2017 Mar 3.
3
Biologic therapy for inflammatory bowel disease.炎症性肠病的生物治疗
Drugs. 2005;65(16):2253-86. doi: 10.2165/00003495-200565160-00002.
4
Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases.辅助性T细胞17作为炎症性肠病潜在的益生菌治疗靶点
Int J Mol Sci. 2015 Sep 1;16(9):20841-58. doi: 10.3390/ijms160920841.
5
Novel strategies for the treatment of inflammatory bowel disease: Selective inhibition of cytokines and adhesion molecules.治疗炎症性肠病的新策略：细胞因子和黏附分子的选择性抑制
World J Gastroenterol. 2006 Aug 7;12(29):4628-35. doi: 10.3748/wjg.v12.i29.4628.
6
Inflammatory Bowel Disease: Updates on Molecular Targets for Biologics.炎症性肠病：生物制剂分子靶点的最新进展
Gut Liver. 2017 Jul 15;11(4):455-463. doi: 10.5009/gnl16308.
7
Meeting summary: Signal transduction pathways in immune and inflammatory cells. November 30-December 3, 2000, Amelia Island, Florida, U.S.A.会议总结：免疫和炎症细胞中的信号转导途径。2000年11月30日至12月3日，美国佛罗里达州阿米莉亚岛
Inflamm Bowel Dis. 2003 Jan;9(1):28-33. doi: 10.1097/00054725-200301000-00005.
8
A Decade of Th9 Cells: Role of Th9 Cells in Inflammatory Bowel Disease.Th9 细胞十年研究进展：Th9 细胞在炎症性肠病中的作用。
Front Immunol. 2018 May 24;9:1139. doi: 10.3389/fimmu.2018.01139. eCollection 2018.
9
Damage-associated molecular patterns in inflammatory bowel disease: From biomarkers to therapeutic targets.炎症性肠病中的损伤相关分子模式：从生物标志物到治疗靶点。
World J Gastroenterol. 2018 Nov 7;24(41):4622-4634. doi: 10.3748/wjg.v24.i41.4622.
10
Alterations in cytokine gene expression profile in colon mucosa of Inflammatory Bowel Disease patients on different therapeutic regimens.接受不同治疗方案的炎症性肠病患者结肠黏膜中细胞因子基因表达谱的改变。
Cytokine. 2017 Apr;92:12-19. doi: 10.1016/j.cyto.2017.01.008. Epub 2017 Jan 12.
引用本文的文献
1
Anti-inflammatory Effects of Novel P2X4 Receptor Antagonists, NC-2600 and NP-1815-PX, in a Murine Model of Colitis.新型 P2X4 受体拮抗剂 NC-2600 和 NP-1815-PX 在结肠炎小鼠模型中的抗炎作用。
Inflammation. 2022 Aug;45(4):1829-1847. doi: 10.1007/s10753-022-01663-8. Epub 2022 Mar 26.
本文引用的文献
1
Global burden of inflammatory bowel disease.炎症性肠病的全球负担。
Lancet Gastroenterol Hepatol. 2020 Jan;5(1):2-3. doi: 10.1016/S2468-1253(19)30358-9. Epub 2019 Oct 21.
2
Cooling Down the Hot Potato: Anti-Interleukin 36 Therapy Prevents and Treats Experimental Intestinal Fibrosis.给烫手山芋降温：抗白细胞介素36疗法预防和治疗实验性肠纤维化
Gastroenterology. 2019 Mar;156(4):871-873. doi: 10.1053/j.gastro.2019.02.007. Epub 2019 Feb 15.
3
Mediators of the Resolution of the Inflammatory Response.炎症反应消退的介质。
Trends Immunol. 2019 Mar;40(3):212-227. doi: 10.1016/j.it.2019.01.007. Epub 2019 Feb 13.
4
The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease.NKG2D/NKG2DL 轴在免疫细胞和髓系细胞相互作用中的作用及其在疾病中的意义。
Front Immunol. 2018 Apr 23;9:827. doi: 10.3389/fimmu.2018.00827. eCollection 2018.
5
Regulation and function of interleukin-36 cytokines.白细胞介素-36 细胞因子的调控和功能。
Immunol Rev. 2018 Jan;281(1):169-178. doi: 10.1111/imr.12610.
6
Anti-NKG2D mAb: A New Treatment for Crohn's Disease?抗 NKG2D mAb：克罗恩病的新疗法？
Int J Mol Sci. 2017 Sep 16;18(9):1997. doi: 10.3390/ijms18091997.
7
Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies.炎症性肠病的发病机制及生物治疗的最新进展
Immune Netw. 2017 Feb;17(1):25-40. doi: 10.4110/in.2017.17.1.25. Epub 2017 Feb 23.
8
Mitochondrial dysfunction in inflammatory bowel disease.炎症性肠病中的线粒体功能障碍。
Front Cell Dev Biol. 2015 Oct 1;3:62. doi: 10.3389/fcell.2015.00062. eCollection 2015.
Zotero 插件